Ftse Mib
33.154,05
-0,10%
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
NASDAQ
17.732,60
-0,71%
Bitcoin
60.962,21
1,08%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cartesian Therapeutics Inc (RNAC) Cartesian Therapeutics Inc (RNAC) Notizie

RNAC

Cartesian Therapeutics (RNAC)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RNAC
DataOraFonteTitoloSimboloCompagnia
06/06/202413:05GlobeNewswire Inc.Cartesian Therapeutics Announces New Employment Inducement GrantNASDAQ:RNACCartesian Therapeutics Inc
22/05/202413:00GlobeNewswire Inc.Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia GravisNASDAQ:RNACCartesian Therapeutics Inc
13/05/202422:30GlobeNewswire Inc.Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNASDAQ:RNACCartesian Therapeutics Inc
08/05/202413:00GlobeNewswire Inc.Cartesian Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:RNACCartesian Therapeutics Inc
06/05/202422:15Business WireCartesian Therapeutics Announces New Employment Inducement GrantsNASDAQ:RNACCartesian Therapeutics Inc
22/04/202422:30Business WireCartesian Therapeutics to Present at the ASGCT 27th Annual MeetingNASDAQ:RNACCartesian Therapeutics Inc
04/04/202413:30Business WireCartesian Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:RNACCartesian Therapeutics Inc
28/03/202421:05GlobeNewswire Inc.Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock SplitNASDAQ:RNACCartesian Therapeutics Inc
07/03/202413:00GlobeNewswire Inc.Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:RNACCartesian Therapeutics Inc
06/03/202413:00GlobeNewswire Inc.Cartesian Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:RNACCartesian Therapeutics Inc
05/03/202413:00GlobeNewswire Inc.Cartesian Therapeutics Establishes New Corporate Headquarters and State-of-the-Art mRNA Cell Therapy cGMP Manufacturing Facility in Frederick, MarylandNASDAQ:RNACCartesian Therapeutics Inc
08/01/202413:10GlobeNewswire Inc.Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for AutoimmunityNASDAQ:RNACCartesian Therapeutics Inc
08/01/202413:00GlobeNewswire Inc.Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia GravisNASDAQ:RNACCartesian Therapeutics Inc
13/11/202314:05GlobeNewswire Inc.Selecta Biosciences Announces Merger with Cartesian TherapeuticsNASDAQ:RNACCartesian Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RNAC

La tua Cronologia

TSX
ZLB
BMO Low Volatility Canad...
TSX
HHLE
Harvest Healthcare Leade...
TG
KSX
KnightSwift Transportation
CEGG
SAFEUSDT
Safe
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network